Quest Diagnostics Inc

US

DGX

Health Care

130.09 ₽

Current price

Sell
130.09 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    220 / 302

  • Position in country

    9578 / 14179

  • Return on Assets, %

    6.6

    0.1

  • Net income margin, %

    8.9

    0.6

  • EBITDA margin, %

    16.1

    8.9

  • Debt to Equity, %

    74.7

    34.4

  • Intangible assets and goodwill, %

    63.4

    15.8

  • Revenue CAGR 3Y, %

    -0.7

    11.7

  • Total Equity change 1Y, %

    7

    0

  • Revenue Y, % chg

    -6.4

    1.8

  • P/E

    17.1

    25.7

  • P/BV

    2.2

    1.2

  • P/S

    1.5

    1.2

  • EV/S

    2

    1.5

  • EV/EBITDA

    10.7

    6.9

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    10.8

    45.6

  • Forward P/E

    14.3

    17.8

  • Dividend Yield, %

    2.3

    2.6

  • Forward Dividend Yield, %

    2.2

    0.4

  • Expected dividend per share

    2.9

    0

  • Payout Ratio, %

    36.9

    18.7

  • Dividend Ex Date

    2024-04-05

Get an analytical review of this company

Competitors

Ranks

  • CorVel Corp

    00%

  • Signify Health Inc

    00%

  • Cigna Group

    00%

  • CVS Health Corp

    00%

  • Option Care Health Inc

    00%

  • Oak Street Health Inc

    00%

  • DaVita Inc

    00%

  • Chemed Corp

    00%

  • Quest Diagnostics Inc

    00%

  • Laboratory Corporation of America Holdings

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Providers & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    14274

  • Ticker

    DGX.N

  • ISIN

    US74834L1008

  • IPO date

    1996-12-17

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-22

  • Date fact. publication of reports

    2023-12-31

Company Description

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: